SOAT1 and triple-negative breast carcinoma: Moreover, Hydroxy-jolkinolide B, Deoxy-2β,16-dihydroxynagilactone E, and Acetoxychavicol acetate inhibit triple negative breast cancer cells by downregulating of JAK/STAT pathway [86].